Proton pump inhibitors: Weighing the benefits and risks across various health conditions

被引：1
|
作者：
Sizgoric, Luka [1 ]
Likic, Robert [1 ,2 ,3 ]
机构：
[1] Univ Zagreb, Med Sch, Zagreb, Croatia
[2] Clin Hosp Ctr Zagreb, Dept Internal Med, Div Clin Pharmacol & Therapeut, Zagreb, Croatia
[3] Univ Hosp Ctr Zagreb, Dept Internal Med, Unit Clin Pharmacol, Kispaticeva 12, Zagreb 10000, Croatia
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2024年 / 90卷 / 02期
关键词：
chronic kidney disease; COVID-19; drug interactions; effects; gastric acid secretion; glycemic dysregulation; proton pump inhibitors;
D O I：
10.1111/bcp.15960
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：388 / 391
页数：4
相关论文
共 44 条
  • [31] Patterns of outpatient proton-pump inhibitors use among older adults in a duplicative health system: comparing public and private prescribing
    Romano, Sonia
    Rodrigues, Antonio Teixeira
    Torre, Carla
    Perelman, Julian
    BMC HEALTH SERVICES RESEARCH, 2025, 25 (01)
  • [32] (De)Prescribing of proton pump inhibitors: what has changed in recent years? an observational regional study from the French health insurance database
    Pauline Gendre
    Julie Mocquard
    Pascal Artarit
    Anicet Chaslerie
    Pascal Caillet
    Jean-François Huon
    BMC Primary Care, 23
  • [33] Clinical Audit Report as preliminary step for Quality Improvement Project on Prescribing Proton Pump Inhibitors for appropriate indications in West Bay Health Center
    Soliman, Samar
    Salem, Mohamed
    Mohamed, Eman
    Khan, Sharief
    Shah, Abdul-Ali
    Yousuf, Wafaa
    WORLD FAMILY MEDICINE, 2020, 18 (11): : 87 - 92
  • [34] Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors
    Kothari, S.
    Nelson, S. P.
    Wu, E. Q.
    Beaulieu, N.
    McHale, J. M.
    Dabbous, O. H.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (11) : 2703 - 2709
  • [35] Associations between proton pump inhibitors and Alzheimer’s disease: a nested case–control study using a Korean nationwide health screening cohort
    Hyo Geun Choi
    Joo-Hee Kim
    Ji Hee Kim
    Eun Soo Kim
    Ha Young Park
    Kyueng-Whan Min
    Mi Jung Kwon
    Alzheimer's Research & Therapy, 14
  • [36] (De)Prescribing of proton pump inhibitors: what has changed in recent years? an observational regional study from the French health insurance database
    Gendre, Pauline
    Mocquard, Julie
    Artarit, Pascal
    Chaslerie, Anicet
    Caillet, Pascal
    Huon, Jean-Francois
    BMC PRIMARY CARE, 2022, 23 (01):
  • [37] Associations between proton pump inhibitors and Alzheimer's disease: a nested case-control study using a Korean nationwide health screening cohort
    Choi, Hyo Geun
    Kim, Joo-Hee
    Kim, Ji Hee
    Kim, Eun Soo
    Park, Ha Young
    Min, Kyueng-Whan
    Kwon, Mi Jung
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [38] A 30-month evaluation of the effects on the cost and utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state employee health plan
    West, DS
    Johnson, JT
    Hong, SH
    JOURNAL OF MANAGED CARE PHARMACY, 2006, 12 (01): : 25 - 32
  • [39] Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrenees region
    Conte, Cecile
    Bourrel, Robert
    Despas, Fabien
    Lapeyre-Mestre, Maryse
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 (03) : 327 - 338
  • [40] Clinical Outcomes in Patients With the Concomitant Use of Clopidogrel and Proton Pump Inhibitors After Percutaneous Coronary Intervention An Analysis From the Guthrie Health Off-Label Stent (GHOST) Investigators
    Harjai, Kishore J.
    Shenoy, Chetan
    Orshaw, Pam
    Usmani, Samer
    Boura, Judy
    Mehta, Rajendra H.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (02) : 162 - 170
12345